153 related articles for article (PubMed ID: 4087260)
1. Sjögren's syndrome: treatment with D-penicillamine and hydroxychloroquine.
Lakhanpal S; Duffy J; Griffing WL; Conn DL; Luthra HS
J Rheumatol; 1985 Oct; 12(5):1028-9. PubMed ID: 4087260
[No Abstract] [Full Text] [Related]
2. Treatment of primary Sjögren's syndrome with D-penicillamine: a pilot study.
ter Borg EJ; Haanen HC; Haas FJ; Bistervels JH; Huisman FW; Kerckhaert JA; Kallenberg CG
Neth J Med; 2002 Nov; 60(10):402-6. PubMed ID: 12607591
[TBL] [Abstract][Full Text] [Related]
3. [Primary Gougerot-Sjögren syndrome. Favourable effect of a fundamental treatment with hydroxychloroquine on biological anomalies].
Chaouat D; Aron Rosa D; Aron B
Rev Rhum Mal Osteoartic; 1988 Oct; 55(10):797-8. PubMed ID: 3194698
[No Abstract] [Full Text] [Related]
4. [Primary Gougerot-Sjögren syndrome with necrotizing polymyositis: favorable effect of hydroxychloroquine].
Ponge T; Mussini JM; Ponge A; Forgeau Y; Barrier J; Cottin S; Grolleau JY
Rev Neurol (Paris); 1987; 143(2):147-8. PubMed ID: 3602794
[TBL] [Abstract][Full Text] [Related]
5. Recognition and management of Sjögren's syndrome: strategies for the advanced practice nurse.
Vale DL
Nurs Clin North Am; 2000 Mar; 35(1):267-78. PubMed ID: 10673580
[TBL] [Abstract][Full Text] [Related]
6. Treatment of primary Sjögren's syndrome with hydroxychloroquine: a retrospective, open-label study.
Fox RI; Dixon R; Guarrasi V; Krubel S
Lupus; 1996 Jun; 5 Suppl 1():S31-6. PubMed ID: 8803908
[TBL] [Abstract][Full Text] [Related]
7. [Subclavian steal syndrome associated with Sjögren's syndrome].
Machtey I
Harefuah; 1973 Aug; 85(4):174-6. PubMed ID: 4756189
[No Abstract] [Full Text] [Related]
8. Systemic vasculitis developing after hydroxychloroquine interruption in a patient with Sjögren's syndrome.
Okan G; Karaaslan M; Büyükbabani N
Clin Exp Dermatol; 2010 Jun; 35(4):442-3. PubMed ID: 19886967
[No Abstract] [Full Text] [Related]
9. Recurrent psoriatic onychoperiostitis induced by hydroxychloroquine.
Sibilia J; Cribier B; Javier RM; Pflumio F; Kuntz JL
Rev Rhum Engl Ed; 1995 Dec; 62(11):795-7. PubMed ID: 8869222
[TBL] [Abstract][Full Text] [Related]
10. Articular manifestations in primary Sjögren's syndrome: clinical significance and prognosis of 188 patients.
Fauchais AL; Ouattara B; Gondran G; Lalloué F; Petit D; Ly K; Lambert M; Launay D; Loustaud-Ratti V; Bezanahari H; Liozon E; Hachulla E; Jauberteau MO; Vidal E; Hatron PY
Rheumatology (Oxford); 2010 Jun; 49(6):1164-72. PubMed ID: 20299380
[TBL] [Abstract][Full Text] [Related]
11. Treatment of sicca symptoms with hydroxychloroquine in patients with Sjogren's syndrome.
Rihl M; Ulbricht K; Schmidt RE; Witte T
Rheumatology (Oxford); 2009 Jul; 48(7):796-9. PubMed ID: 19433433
[TBL] [Abstract][Full Text] [Related]
12. Hydroxychloroquine therapy in patients with primary Sjögren's syndrome may improve salivary gland hypofunction by inhibition of glandular cholinesterase.
Dawson LJ; Caulfield VL; Stanbury JB; Field AE; Christmas SE; Smith PM
Rheumatology (Oxford); 2005 Apr; 44(4):449-55. PubMed ID: 15590764
[TBL] [Abstract][Full Text] [Related]
13. Hydroxychloroquine treatment for primary Sjögren's syndrome: a two year double blind crossover trial.
Kruize AA; Hené RJ; Kallenberg CG; van Bijsterveld OP; van der Heide A; Kater L; Bijlsma JW
Ann Rheum Dis; 1993 May; 52(5):360-4. PubMed ID: 8323383
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of the clinical efficacy of yiqi fumai injection combined hydroxychloroquine sulfate tablet for treating Sjogren's syndrome].
Chen FY; Xue B; Wang H
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Dec; 32(12):1621-3. PubMed ID: 23469599
[TBL] [Abstract][Full Text] [Related]
15. D-penicillamine treatment for chronic sensory ataxic neuropathy associated with Sjögren's syndrome.
Asahina M; Kuwabara S; Asahina M; Nakajima M; Hattori T
Neurology; 1998 Nov; 51(5):1451-3. PubMed ID: 9818879
[TBL] [Abstract][Full Text] [Related]
16. Effects of hydroxychloroquine on salivary flow rates and oral complaints of Sjögren patients: a prospective sample study.
Cankaya H; Alpöz E; Karabulut G; Güneri P; Boyacioglu H; Kabasakal Y
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Jul; 110(1):62-7. PubMed ID: 20610299
[TBL] [Abstract][Full Text] [Related]
17. Management of patients presenting with Sjogren's syndrome.
Venables PJ
Best Pract Res Clin Rheumatol; 2006 Aug; 20(4):791-807. PubMed ID: 16979538
[TBL] [Abstract][Full Text] [Related]
18. [Thrombopenia secondary to hydroxychloroquine].
Caminal Montero L; González Marroquín A; Ferro Mosquera J; Susano R
An Med Interna; 1994 Jun; 11(6):310. PubMed ID: 7918951
[No Abstract] [Full Text] [Related]
19. Treatment of primary Sjögren's syndrome with hydroxychloroquine.
Fox RI; Chan E; Benton L; Fong S; Friedlaender M; Howell FV
Am J Med; 1988 Oct; 85(4A):62-7. PubMed ID: 3177432
[TBL] [Abstract][Full Text] [Related]
20. Treatment of Sjögren's syndrome by delagil.
Deseö E
Ther Hung; 1968; 16(2):74-7. PubMed ID: 5666418
[No Abstract] [Full Text] [Related]
[Next] [New Search]
